298 related articles for article (PubMed ID: 14987916)
1. Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients.
Bachleitner-Hofmann T; Grumbeck E; Gisslinger H
Thromb Res; 2003; 112(4):229-32. PubMed ID: 14987916
[TBL] [Abstract][Full Text] [Related]
2. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
3. A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP).
Finazzi G;
Pathol Biol (Paris); 2004 Jun; 52(5):285-8. PubMed ID: 15217715
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.
Palareti G; Legnani C; Lee A; Manotti C; Hirsh J; D'Angelo A; Pengo V; Moia M; Coccheri S
Thromb Haemost; 2000 Nov; 84(5):805-10. PubMed ID: 11127860
[TBL] [Abstract][Full Text] [Related]
5. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
6. European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP): a randomized trial.
Landolfi R; Marchioli R
Semin Thromb Hemost; 1997; 23(5):473-8. PubMed ID: 9387206
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and prevention of vascular complications in polycythemia vera.
Barbui T; Finazzi G
Semin Thromb Hemost; 1997; 23(5):455-61. PubMed ID: 9387204
[TBL] [Abstract][Full Text] [Related]
8. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia.
Randi ML; Fabris F; Ruzzon E; Pacquola E; Cella G; Girolami A
Haematologica; 2002 Nov; 87(11):1180-4. PubMed ID: 12414348
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs.
Crisà E; Venturino E; Passera R; Prina M; Schinco P; Borchiellini A; Giai V; Ciocca Vasino MA; Bazzan M; Vaccarino A; Boccadoro M; Ferrero D
Ann Hematol; 2010 Jul; 89(7):691-9. PubMed ID: 20146064
[TBL] [Abstract][Full Text] [Related]
10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation after coronary artery surgery in patients with polycythemia vera: report of two cases.
Oz BS; Asgun F; Akay HT; Kaya E; Kuralay E; Tatar H
J Card Surg; 2007; 22(5):420-2. PubMed ID: 17803581
[TBL] [Abstract][Full Text] [Related]
13. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome.
Cruz E; Ascher NL; Roberts JP; Bass NM; Yao FY
Clin Transplant; 2005 Aug; 19(4):501-6. PubMed ID: 16008595
[TBL] [Abstract][Full Text] [Related]
14. Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera.
Gangat N; Wolanskyj AP; Schwager SM; Hanson CA; Tefferi A
Cancer; 2009 Dec; 115(24):5740-5. PubMed ID: 19806641
[TBL] [Abstract][Full Text] [Related]
15. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy).
Palareti G; Manotti C; DAngelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berrettini M; Leali N; Poggi M; Legnani C; Musolesi S; Coccheri S
Thromb Haemost; 1997 Dec; 78(6):1438-43. PubMed ID: 9423791
[TBL] [Abstract][Full Text] [Related]
17. Polycythemia vera and essential thrombocythemia in young patients.
Frezzato M; Ruggeri M; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):11-7. PubMed ID: 8039752
[TBL] [Abstract][Full Text] [Related]
18. Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Leone G; Barbui T;
Am J Hematol; 2010 Feb; 85(2):97-100. PubMed ID: 20052743
[TBL] [Abstract][Full Text] [Related]
19. Hemorrhagic and thrombotic complications in polycythemia vera. A clinical study.
Orlandi E; Castelli G; Brusamolino E; Canevari A; Morra E; Lazzarino M; Bernasconi C
Haematologica; 1989; 74(1):45-9. PubMed ID: 2498182
[TBL] [Abstract][Full Text] [Related]
20. Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis.
Bucalossi A; Marotta G; Bigazzi C; Galieni P; Dispensa E
Am J Hematol; 1996 May; 52(1):14-20. PubMed ID: 8638606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
